Semi-Annual Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7298504

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
23,600,000,000 JPY
1,278,000,000 JPY
Interest and dividends received
301,000,000 JPY
255,000,000 JPY
Interest paid
-12,000,000 JPY
-8,000,000 JPY
Net cash provided by (used in) operating activities
23,932,000,000 JPY
-245,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,961,000,000 JPY
-734,000,000 JPY
Purchase of investment securities
-200,000,000 JPY
JPY
Proceeds from sale of investment securities
JPY
8,000,000 JPY
Other, net
-209,000,000 JPY
-228,000,000 JPY
Net cash provided by (used in) investing activities
-2,432,000,000 JPY
-1,141,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,840,000,000 JPY
-2,813,000,000 JPY
Net cash provided by (used in) financing activities
-2,839,000,000 JPY
-2,813,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
18,661,000,000 JPY
-4,199,000,000 JPY
Cash and cash equivalents
83,987,000,000 JPY
65,325,000,000 JPY
70,060,000,000 JPY
74,260,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.